Amitriptyline and perphenazine and Triaminic Decongestant
Determining the interaction of Amitriptyline and perphenazine and Triaminic Decongestant and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Coadministration with tri- or tetra-cyclic antidepressants may theoretically potentiate the sympathomimetic effects (e.g., hypertension, tachycardia) of systemically absorbed xylometazoline following topical (i.e., nasal) administration. The proposed mechanism may involve additive or synergistic increases in circulating catecholamines, such as noradrenaline (norepinephrine). MANAGEMENT: Until further information is available, caution is advised if a tri- or tetra-cyclic antidepressant is used concomitantly with topical xylometazoline. Blood pressure and heart rate should be monitored at regular intervals during concomitant therapy. A dose reduction or discontinuation of concomitant therapy should be considered in patients who experience a sustained increase in blood pressure or heart rate. References Agencia Española de Medicamentos y Productos Sanitarios Healthcare "Centro de información online de medicamentos de la AEMPS - CIMA. Available from: URL: https://cima.aemps.es/cima/publico/home.html." ([2018]): Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Professional:MONITOR: Coadministration with tri- or tetra-cyclic antidepressants may theoretically potentiate the sympathomimetic effects (e.g., hypertension, tachycardia) of systemically absorbed xylometazoline following topical (i.e., nasal) administration. The proposed mechanism may involve additive or synergistic increases in circulating catecholamines, such as noradrenaline (norepinephrine).
MANAGEMENT: Until further information is available, caution is advised if a tri- or tetra-cyclic antidepressant is used concomitantly with topical xylometazoline. Blood pressure and heart rate should be monitored at regular intervals during concomitant therapy. A dose reduction or discontinuation of concomitant therapy should be considered in patients who experience a sustained increase in blood pressure or heart rate.
- Agencia Española de Medicamentos y Productos Sanitarios Healthcare "Centro de información online de medicamentos de la AEMPS - CIMA. Available from: URL: https://cima.aemps.es/cima/publico/home.html." ([2018]):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: amitriptyline / perphenazine
Brand name: Etrafon Forte, Triavil, Etrafon 2-10, Etrafon 2-25
Synonyms: Amitriptyline and Perphenazine
Generic Name: xylometazoline nasal
Brand name: Triaminic Decongestant, Otrivin
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amitriptyline and perphenazine-Triaminic Decongestant/Cough Infant
- Amitriptyline and perphenazine-Triaminic Fever Reducer
- Amitriptyline and perphenazine-Triaminic Flu Cough & Fever
- Amitriptyline and perphenazine-Triaminic Long Acting Cough
- Amitriptyline and perphenazine-Triaminic Multi-Symptom Fever
- Amitriptyline and perphenazine-Triaminic Night Time Cold & Cough
- Triaminic Decongestant-Amitriptyline Hydrochloride
- Triaminic Decongestant-Amjevita Subcutaneous
- Triaminic Decongestant-Amlobenz
- Triaminic Decongestant-Amlodipine
- Triaminic Decongestant-Amlodipine and atorvastatin
- Triaminic Decongestant-Amlodipine and Atorvastatin Tablets